You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stage IIIC and Stage IV BRAFV600E Melanoma

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cutaneous Melanoma, Melanoma, Melanoma of Unknown Primary Trial in United States (DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly

Completed
Has Results
  • Cutaneous Melanoma
  • +11 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +2 more
  • Chicago, Illinois
  • +6 more
Nov 10, 2021

Malignant Female Reproductive System Tumor, Malignant Hepatobiliary Tumor, Partner Trial in New Brunswick (Cognitive Behavior

Completed
  • Malignant Female Reproductive System Neoplasm
  • +38 more
  • Cognitive Behavior Therapy
  • +3 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Apr 7, 2021

Melanoma Trial in New York (Dabrafenib)

Completed
Has Results
  • Melanoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 8, 2020

BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Metastatic Thyroid Gland Carcinoma Trial in Portland (Binimetinib,

Recruiting
  • BRAF NP_004324.2:p.V600M
  • +6 more
  • Portland, Oregon
    Providence Portland Medical Center
Aug 17, 2022

BRAF NP_004324.2:p.V600X, KRAS wt Allele, Metastatic Malignant Solid Tumor Trial in Houston (biological, drug, other)

Active, not recruiting
  • BRAF NP_004324.2:p.V600X
  • +6 more
  • Cetuximab
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Advanced Endometrial Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston

Recruiting
  • Advanced Endometrial Carcinoma
  • +36 more
  • Glutaminase Inhibitor IPN60090
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Sep 9, 2021

Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma Trial in United States (trametinib, laboratory biomarker analysis,

Completed
Has Results
  • Recurrent Melanoma
  • +3 more
  • Washington, District of Columbia
  • +3 more
May 4, 2021

Melanoma Stage III, Melanoma Stage IV, Unresectable Melanoma Trial in Worldwide (BNT111, Cemiplimab)

Recruiting
  • Melanoma Stage III
  • +2 more
  • BNT111
  • Cemiplimab
  • Tucson, Arizona
  • +53 more
Aug 24, 2022

Bone Loss in Melanoma Survivors Receiving Immunotherapy

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +7 more
  • Biospecimen Collection
  • Dual X-ray Absorptiometry
  • Houston, Texas
    M D Anderson Cancer Center
Aug 2, 2021

Stage III/IV Melanoma Trial in Worldwide (tavokinogene telseplasmid, Pembrolizumab, ImmunoPulse)

Recruiting
  • Stage III/IV Melanoma
  • tavokinogene telseplasmid
  • +2 more
  • Tucson, Arizona
  • +37 more
Dec 21, 2022

Advanced Colorectal Carcinoma, Advanced Digestive System Carcinoma, Advanced Gastric Carcinoma Trial in United States

Recruiting
  • Advanced Colorectal Carcinoma
  • +42 more
  • Duarte, California
  • +9 more
Jan 21, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,

Recruiting
  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +26 more
  • Biopsy
  • +5 more
  • Newark, Delaware
  • +52 more
Feb 2, 2023

Untreated Stage III Melanoma or Stage IV Melanoma Trial in Montreal (Ipilimumab, Carboplatin, Paclitaxel)

Active, not recruiting
  • Untreated Stage III Melanoma or Stage IV Melanoma
  • Ipilimumab
  • +2 more
  • Montreal, Quebec, Canada
    Jewish General Hospital
Feb 17, 2021

Advanced Solid Tumors Trial in Boston (Golvatinib, Lenvatinib)

Terminated
Has Results
  • Advanced Solid Tumors
  • Boston, Massachusetts
  • +1 more
May 12, 2021

Melanoma Trial in Cambridge (Dabrafenib, Trametinib)

Completed
  • Melanoma
  • Cambridge, England, United Kingdom
    Addenbrooke's Hospital
Dec 4, 2020

Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Los Angeles, Salt Lake

Terminated
  • Metastatic Melanoma
  • +5 more
  • Anti-SEMA4D Monoclonal Antibody VX15/2503
  • +4 more
  • Los Angeles, California
  • +1 more
Apr 1, 2021

Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage III Gastric Cancer AJCC v8

Recruiting
  • Advanced Gastric Adenocarcinoma
  • +32 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 2, 2022

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +24 more
  • 18F-Fluoromisonidazole
  • +4 more
  • La Jolla, California
  • +15 more
Jan 3, 2023

Head and Neck Squamous Cell Carcinoma, Lung Non-Small Cell Carcinoma, Stage I Cutaneous Squamous Cell Carcinoma of the Head and

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +17 more
  • Best Practice
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 19, 2022

National Cancer Institute "Cancer Moonshot Biobank"

Recruiting
  • Acute Myeloid Leukemia
  • +33 more
  • Biospecimen Collection
  • Medical Chart Review
  • Kingman, Arizona
  • +99 more
Nov 3, 2022

BRAF V600E Negative, KRAS Gene Mutation Negative, Locally Advanced Unresectable Colorectal Adenocarcinoma Trial in United States

Recruiting
  • BRAF V600E Negative
  • +12 more
  • Cetuximab
  • +3 more
  • Scottsdale, Arizona
  • +15 more
Aug 23, 2022

Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in

Active, not recruiting
Has Results
  • Metastatic Melanoma
  • +22 more
  • Ipilimumab
  • +3 more
  • Birmingham, Alabama
  • +24 more
Jan 19, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +38 more
  • Scottsdale, Arizona
  • +2 more
Aug 27, 2021

Malignant Melanoma Trial in France, Germany (Vemurafenib, Cobimetinib, Atezolizumab)

Terminated
  • Malignant Melanoma
  • Marseille, France
  • +6 more
Jan 29, 2021

Melanoma (Skin) Trial in Los Angeles (CP-675,206)

Completed
Has Results
  • Melanoma (Skin)
  • CP-675,206
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Oct 1, 2020